Table 1.

Characteristics of leukemias induced by MLL fusion proteins

Latency, dWBC counts, 106/mLBlasts in PB, %Spleen weight, gLiver weight, g
Control N/A 6.9 ± 1.2 0 ± 0 0.12 ± 0.03 0.45 ± 0.12 
MLL-FKHRL1* 157 ± 70 11.7 ± 8.3 2 ± 1 0.4 ± 0.11 0.94 ± 0.21 
MLL-AFX* 185 ± 115 10.7 ± 7.3 5 ± 2 0.5 ± 0.13 1.13 ± 0.28 
MLL-AF10* 52 ± 8 222 ± 94 54 ± 24 1.80 ± 0.24 2.25 ± 0.45 
Latency, dWBC counts, 106/mLBlasts in PB, %Spleen weight, gLiver weight, g
Control N/A 6.9 ± 1.2 0 ± 0 0.12 ± 0.03 0.45 ± 0.12 
MLL-FKHRL1* 157 ± 70 11.7 ± 8.3 2 ± 1 0.4 ± 0.11 0.94 ± 0.21 
MLL-AFX* 185 ± 115 10.7 ± 7.3 5 ± 2 0.5 ± 0.13 1.13 ± 0.28 
MLL-AF10* 52 ± 8 222 ± 94 54 ± 24 1.80 ± 0.24 2.25 ± 0.45 

WBC indicates white blood cell; PB, peripheral blood; and N/A, not applicable.

*

Values shown are the mean (± SEM) from MLL-FKHRL1 (n = 6), MLL-AFX (n = 10), and MLL-AF10 (n = 10) mice at the time mice were killed.

Close Modal

or Create an Account

Close Modal
Close Modal